Global Cellulite Treatment Market

Market Value•  Global Cellulite Treatment market revenue is expected to expand at impressive CAGR of 7.7%  over the forecast period to reach value of US$ 5,227.7  Mn by 2028 end
•  In terms of revenue, Non-invasive treatment procedure segment is projected to remain the dominant it is expected to gain traction due to high demand from specialized dermatology clinics  and hospitals
•  Soft cellulite segment is expected to gain significant market share over the forecast period due to high number of obesity population
•  Among all end users, Specialized dermatology clinics dominated the global market by 50.1% share in 2018
•  North America is considered to be a lucrative marketplace for the global cellulite treatment market and estimated to retain over 39.8% (2018) of the global market share during 2018–2028

Macro-economic Factors:

•  Increasing Cosmetic Surgery Procedures
•  Rise In Global Annual Disposable Income Per Capita


•  Increasing self awareness among the consumers
•  Rising prevalence of fat deposition related disorders requiring better treatment options


•  Increasing preference for non-surgical procedures in U.S., the largest market
•  Increasing inclination towards aesthetic procedures

Competitive Landscape:

•  Merz Pharma GmbH & Co. KGaA
•  Cynosure, Inc. (Sub. Hologic Inc.)
•  Tanceuticals, LLC.
•  Inceler Medikal Co. Ltd.
•  Cymedics
•  Nubway
•  Zimmer Aesthetics
•  Syneron Medical Inc

Share By Treatment

Overall Market Approach:

•  Research collaborations and partnerships between research institutes and technology companies is the prominent trend observed in global cellulite treatment market
•  Adoption of newer marketing strategy by device manufacturers to attract problem suffering population effecting with normal requirement of these devices at lower price


Key Segments:

•  Non-Invasive segment contributed highest market share and will continue to do so due to focused development of Rising prevalence of fat deposition related disorders requiring better treatment options
•  Development of topical treatment would have higher impact on penetration

Target Country:

•  The U.S. being highly growth market and possess expertise and resources, is expected to continue to dominate the global market
•  Majority of manufacturers of cellulite treatment are focusing to launch their product in emerging market due to chances of early approval that by FDA  

Differentiating Strategy:

•  Manufacturers of cellulite treatment are focusing to raise capital required for launch of new products or research and development expenses through venture financing
•  Company are also resorting to hiring of CMOs and CDMOs in order to reduce operational costs and improve overall productivity

Wheel Of Fortune




Latest Issue
Get instant
access to our latest e-book
Sanofi Harvard Medical School - Leadership in Medicine: Southeast Asia Medlab Middle East 2023 Dubai Derma 2023